Olaratumab (LY3012207) Patient Access for Soft Tissue Sarcoma

Study of the Safety and Pharmacokinetics of Olaratumab (IMC-3G3) in Japanese Participants With Solid Tumors

NCT01199822 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1 Study of LY2787106 in Cancer and Anemia

NCT01340976 ·Status: COMPLETED ·Phase: PHASE1

A Phase I Study With Lymfactin® in the Treatment of Patients With Secondary Lymphedema

NCT02994771 ·Status: TERMINATED ·Phase: PHASE1

Sotrastaurin Acetate in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia, Prolymphocytic Leukemia, or Richter's Transformation

NCT02285244 ·Status: WITHDRAWN ·Phase: PHASE2

Dose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And Ifosfamide

NCT00358540 ·Status: COMPLETED ·Phase: PHASE1

Safety of Simvastatin in LAM and TSC

NCT02061397 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

NCT01594723 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study in Participants With Acute Leukemia

NCT01214603 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel

NCT07149857 ·Status: RECRUITING ·Phase: PHASE2

Trial Evaluating the Efficacy and Safety of Daratumumab in Subjects With Relapsed/Refractory B-cell or T-cell Precursor Acute Lymphoblastic Leukemia (ALL)

NCT03207542 ·Status: WITHDRAWN ·Phase: PHASE2

A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory Neuroblastoma

NCT04106219 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia

NCT01550185 ·Status: TERMINATED ·Phase: PHASE1

A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCT06588478 ·Status: RECRUITING ·Phase: PHASE2

A Study of Elacytarabine (CP-4055) Plus Idarubicin as Second Course Remission-Induction Therapy in Patients With Acute Myeloid Leukaemia

NCT01035502 ·Status: COMPLETED ·Phase: PHASE2

Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative Neoplasms

NCT01520220 ·Status: COMPLETED ·Phase: PHASE1

Clinical Study With Lymfactin® in the Treatment of Patients With Secondary Lymphedema (AdeLE)

NCT03658967 ·Status: COMPLETED ·Phase: PHASE2

A Study to Investigate the Sequencing Strategy of Pirtobrutinib After Disease Progression on First-line Acalabrutinib Treatment for Adult Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT06839872 ·Status: WITHDRAWN ·Phase: PHASE2

MAP to Provide Access to Nilotinib, for Patients With Relapsed or Refractory Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

NCT04559555 ·Status: NO_LONGER_AVAILABLE

FT538 in Subjects With Advanced Hematologic Malignancies

NCT04614636 ·Status: TERMINATED ·Phase: PHASE1

Study of Oral LOXO-338 in Patients With Advanced Blood Cancers

NCT05024045 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Study of Abemaciclib in Dedifferentiated Liposarcoma

NCT02846987 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

The Pharmacokinetics and Cardiac Properties of Elacytarabine (CP-4055)

NCT01258816 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

NCT07008118 ·Status: RECRUITING ·Phase: PHASE1

Phase II Eltrombopag in Chronic Lymphocytic Leukemia (CLL)

NCT01168921 ·Status: COMPLETED ·Phase: PHASE2

Phase II Study of Lenalidomide and Eltrombopag in Patients With Symptomatic Anemia

NCT01772420 ·Status: COMPLETED ·Phase: PHASE2